AKASA develops generative AI solutions for the healthcare revenue cycle. Founded in 2018 and headquartered in South San Francisco, California, the company has raised over $205 million in funding to support its work in applying large language models to complex healthcare administrative tasks.
The company's core offering, the AKASA Platform, integrates proprietary generative AI technology with revenue cycle expertise. The platform automates workflows spanning prior authorization, clinical documentation improvement, medical coding, and claims management. Its approach involves training large language models on each health system's own clinical and financial data, tailoring the AI to specific institutional contexts.
AKASA's solutions are deployed across more than 650 hospitals and 6,500 outpatient facilities in all 50 US states. The company focuses exclusively on the healthcare vertical, building AI systems designed to address the specific demands of clinical and financial operations in that sector.
